ABSTRACT
This article describes a new method for the fabrication of an index for definitive implant abutment selection, framework design, and fabrication. After the interim removable restoration is esthetically and functionally accepted by the patient and dentist, it can be used as a surgical guide during implant placement as well as a guide for abutment selection, framework design, and fabrication. The concepts used in the fabrication of the cross-mounting buccal index include having a reference point, maintaining the vertical dimension of occlusion, and supplying the ability for cross mounting. This procedure allows the clinician to use a duplicate of the interim restoration to select the abutments and fabricate the framework without a new denture setup. It also accelerates both patient chairtime and laboratory time, and it enhances the prosthodontic outcome.
Subject(s)
Dental Prosthesis Design , Dental Prosthesis, Implant-Supported , Denture, Complete, Immediate , Dental Restoration, Temporary , Female , Humans , Models, Dental , Patient Care Planning , Vertical DimensionABSTRACT
A new method of long term, retrospective evaluation of the lipid metabolism balance, by cholesterol and lipid assays in the human hair, is described. The correlation index between the blood and the hair cholesterol and lipid concentrations was + 0.980 and + 0.9925, respectively. The effects of hypolipemic diet and drug therapy on the cholesterol and lipid values were studied comparatively in the blood and in successive hair segments. The results demonstrate that the new method permits an evaluation of the therapy effectiveness and of the lipid metabolism variations during several weeks or months.
Subject(s)
Cholesterol/analysis , Hair/chemistry , Lipids/analysis , Cholesterol/metabolism , Hair/metabolism , Humans , Hypercholesterolemia/metabolism , Hyperlipidemias/metabolism , Lipid Metabolism , Obesity/metabolism , Reference Values , Time FactorsABSTRACT
In a group of 51 women who had given birth to giant children, the glucose tolerance test (GTT) was performed at entry in the study and after intervals of 6 to 12 years. The results of the first determination, estimated according to the WHO's criteria (1980), have revealed an impaired glucose tolerance (IGT) in 7 cases (14%); the second determination showed IGT in 10 cases (20%) and diabetes mellitus in 2 (4%). Insulinemia assays, concomitant with the second performance of GTT, showed the highest values in the diabetic subjects, moderate values in those with IGT, and low values in those with normal glucose tolerance. The presence of obesity in some cases could not be considered as fully responsible for the glucose tolerance impairment in the women with fetal gigantism. The dynamics of glucose tolerance disorders showed variations in time, i.e. the initial pathologic changes were no more recorded on the second testing in the same subjects, while women with normal initial GTT showed high insulinemia or IGT on the second determination.
Subject(s)
Fetal Diseases/etiology , Gigantism/etiology , Glucose Tolerance Test , Obesity/blood , Pregnancy Complications/blood , Pregnancy in Diabetics/blood , Adult , Blood Glucose/metabolism , Female , Humans , Infant, Newborn , Insulin/blood , Prediabetic State/blood , PregnancySubject(s)
Diet Surveys , Nutrition Surveys , Students , Universities , Adolescent , Adult , Female , Humans , Male , RomaniaSubject(s)
Diet Surveys , Nutrition Surveys , Students , Universities , Adult , Dietary Carbohydrates , Dietary Fats , Dietary Proteins , Energy Intake , Female , Humans , Male , RomaniaSubject(s)
Carbohydrate Metabolism , Diabetes Mellitus/diagnosis , Glucose Tolerance Test , Adult , Diabetes Mellitus/metabolism , Female , Humans , Male , ObesityABSTRACT
Using a two stages screening method the prevalence in the general population of hyperlipoproteinemias (HLP), separated in the five types proposed by Fredrickson, Levy and Lees, and adopted by WHO has been studied. The study included 7,085 subjects of both sexes, aged 25-65 years, representing 84,52 % of a population taken at random within a district of Bucarest. HLP was found in 1,013 cases, i.e. 14,29 % of the investigated population. 48.37 % were men and 51.63 % women. The prevalence of HLP was lowest in the first decace of age studied (25-35 years) and highest in the last two decades (45-65 years). Overweight was more frequently encountered in these patients (64.46 %) than in the total population (32.3 %). Of the 1,013 cases with HLP, 42.35 % (6.05 % of the total population) were of type IV, 27.05 % (3.86 % of the total population) of type II-b, 22.80 % (3.26 % of the total population) of type II-a, 4.74 % (0.67 % of the total population) of the type III and 3.06 % (0.43 % of the total population) of the type V. 22.70 % of the HLP patients were considered primary familial HLP, 66.54 % primary non-familial HLP and 10.76 % secondary HLP; IN 109 secondary HLP, the most frequently encountered disease was diabetes mellitus (42.20 %), followed by hypothyroidism (24.77 %), alcoholism (12.84 %), obstructive liver diseases (9.17 %), pancreatitis (5.50 %), nephrotic syndrome (2.75 %) and treatment with estrogens and steroids (2.75 %).
